Skip to main content
. 2023 Nov 9;19(3):2275962. doi: 10.1080/21645515.2023.2275962

Table 4.

Variables associated with higher self-reported vaccination side effects scores (SERVASE) following COVID-19 vaccination in multinomial logistic regression analyses.

Model aORc (95% CId) p value
SERVASE 1 < 8 vs. SERVASE 1 ≥ 8    
Nagelkerke R2  = 0.164    
Male 2.90 (1.70–4.93) <.001
Female Ref.  
Student 0.45 (0.25–0.81) .007
Academic staff Ref.  
Pfizer-BioNTech COVID-19 vaccine 2.35 (1.20–4.61) .012
Oxford – AstraZeneca COVID-19 vaccine Ref.  
Mini-VCBSa <9 1.60 (0.87–2.96) .134
Mini-VCBS = 9 1.86 (0.90–3.82) .093
Mini-VCBS >9 Ref.  
SMVb <9 1.83 (0.99–3.40) .056
SMV = 9 1.77 (0.64–4.86) .270
SMV >9 Ref.  
SERVASE 2 < 8 vs. SERVASE 2 ≥ 8    
Nagelkerke R2  = 0.167    
Male 2.91 (1.68–5.04) <.001
Female Ref.  
Age ≤22 years 0.75 (0.34–1.65) .474
Age >22 years Ref.  
Undergraduate 1.04 (0.39–2.76) .943
Postgraduate Ref.  
Student 0.71 (0.28–1.78) .460
Academic staff Ref.  
Mini-VCBS <9 2.14 (1.14–4.04) .019
Mini-VCBS = 9 2.64 (1.26–5.55) .010
Mini-VCBS >9 Ref.  
SMV <9 1.94 (1.02–3.68) .042
SMV = 9 1.16 (0.43–3.16) .774
SMV >9 Ref.  
SERVASE 3 < 8 vs. SERVASE 3 ≥ 8    
Nagelkerke R2  = 0.266    
Male 4.07 (2.12–7.79) <.001
Female Ref.  
Student 0.54 (0.27–1.08) .080
Academic staff Ref.  
History of COVID-19 0.90 (0.47–1.73) .760
No history of COVID-19 Ref.  
Pfizer-BioNTech COVID-19 vaccine 2.49 (0.84–7.33) .099
Oxford – AstraZeneca COVID-19 vaccine Ref.  
Mini-VCBS <9 1.51 (0.70–3.23) .292
Mini-VCBS = 9 4.60 (1.88–11.28) .001
Mini-VCBS >9 Ref.  
SMV <9 2.87 (1.31–6.27) .008
SMV = 9 1.05 (0.32–3.47) .938
SMV >9 Ref.  

aMini-VCBS: miniaturized version of the Vaccine Conspiracy Beliefs Scale with higher scores indicating higher embrace of vaccine conspiracies and a score of 9 indicated a neutral attitude; bSMV: the Score for Mandatory Vaccination with higher scores indicating disagreement toward mandatory vaccination and a score of 9 indicated a neutral attitude; caOR: Adjusted odds ratio; dCI: confidence interval.